Proteomic approaches in understanding a detected relationship between chemotherapy-induced nephrotoxicity and cell respiration in HK-2 cells

Nephron - Physiology

Volumn 119, Issue 1, 2011, Pages

  Perez, Juliana Dinéia ^a   Colucci, Juliana Almada ^a   Sakata, Maísa Mayumi ^a   Cunha, Tatiana Sousa ^a   Arita, Danielle Yuri ^a   Casarini, Dulce Elena ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemotherapeutic agents; HK 2; Mass spectrometer; Nephrotoxicity; Proteomics; Two dimensional gel electrophoresis

Indexed keywords

CARBOPLATIN; CISPLATIN; GLYCINE HYDROXYMETHYLTRANSFERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; THIOREDOXIN REDUCTASE; XENOBIOTIC AGENT;

AMINO ACID SEQUENCE; ARTICLE; CANCER CHEMOTHERAPY; CELL RESPIRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CELL LINE; CELL RESPIRATION; CISPLATIN; DRUG TOXICITY; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; KIDNEY; NEOPLASMS; PEROXIREDOXINS; PROTEOME; PROTEOMICS; PROTON-TRANSLOCATING ATPASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 79958049201     PISSN: 16602110     EISSN: 16602137     Source Type: Journal    
DOI: 10.1159/000327575     Document Type: Article

References (29)

1. Boyle P, Levin B: World Health Organization. World Cancer Report. Lyon, International Agency for Research on Cancer, 2008, vol 12.
2. Suzuki R, Rao P, Sasaguri S: Current status and future of target-based therapeutics. Curr Cancer Drug Targets 2007; 7: 273-284. (Pubitemid 46699078)
3. Go RS, Adjei AA: Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 1999; 17: 409-422. (Pubitemid 29022420)
4. Ries F, Klastersky J: Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis 1986; 8: 368-379. (Pubitemid 17235084)
5. Gonzalez-Vitale JC, et al: Acute renal failure after cis -dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies. Cancer Treat Rep 1978; 62: 693-698. (Pubitemid 8371321)
6. Wolfgang GH, et al: Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats. Fundam Appl Toxicol 1994; 22: 73-79. (Pubitemid 24073659)
7. Grantham JJ: Studies of organic anion and cation transport in isolated segments of proximal tubules. Kidney Int 1982; 22: 519-525. (Pubitemid 13255090)
8. Davila JC, et al: Predictive value of in vitro model systems in toxicology. Annu Rev Pharmacol Toxicol 1998; 38: 63-96. (Pubitemid 28231489)
9. Cohen AA, et al: Dynamic proteomics of individual cancer cells in response to a drug. Science 2008; 322: 1511-1516.
10. Hawkridge AM, Muddiman DC: Mass spectrometry- based biomarker discovery: Toward a global proteome index of individuality. Annu Rev Anal Chem 2009; 2: 265-277.
11. Wilm M: Quantitative proteomics in biological research. Proteomics 2009; 9: 4590-4605.
12. Knepper MA: Proteomics and the kidney. J Am Soc Nephrol 2002; 13: 1398-1408. (Pubitemid 34441423)
13. Bandara LR, Kennedy S: Toxicoproteomics - a new preclinical tool. Drug Discov Today 2002; 7: 411-418. (Pubitemid 34251108)
14. Okamura N, et al: Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma. Proteomics 2008; 8: 3194-3203.
15. Good DM, et al: Body fluid proteomics for biomarker discovery: Lessons from the past hold the key to success in the future. J Proteome Res 2007; 6: 4549-4555.
16. Bates RC, et al: Apoptosis induced by inhibition of intercellular contact. J Cell Biol 1994; 125: 403-415. (Pubitemid 24135953)
17. Thadhani R, Pascual M, Bonventre JV: Acute renal failure. N Engl J Med 1996; 334: 1448-1460. (Pubitemid 126590563)
18. Roura S, et al: Regulation of E-cadherin/ catenin association by tyrosine phosphorylation. J Biol Chem 1999; 274: 36734-36740.
19. Zhang X, et al: Effect of citrate on malignant pleural mesothelioma cells: A synergistic effect with cisplatin. Anticancer Res 2009; 29: 1249-1254.
20. Pedersen PL: Mitochondrial events in the life and death of animal cells: A brief overview. J Bioenerg Biomembr 1999; 31: 291-304. (Pubitemid 30058565)
21. Wallace DC: Mitochondrial diseases in man and mouse. Science 1999; 283: 1482-1488.
22. Scheffler NK, et al: Two-dimensional electrophoresis and mass spectrometric identification of mitochondrial proteins from an SH-SY5Y neuroblastoma cell line. Mitochondrion 2001; 1: 161-179. (Pubitemid 33586027)
23. Emanuel JR, et al: Differential expression of Na + , K + -ATPase alpha- and beta-subunit mRNAs in rat tissues and cell lines. Proc Natl Acad Sci USA 1987; 84: 9030-9034.
24. Weinberg JM, et al: Cytoprotective effects of glycine and glutathione against hypoxic injury to renal tubules. J Clin Invest 1987; 80: 1446-1454. (Pubitemid 18027789)
25. Zhong Z, et al: Cyclosporin A increases hypoxia and free radical production in rat kidneys: Prevention by dietary glycine. Am J Physiol 1998; 275:F595-F604.
26. Holmgren A: Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 264: 13963-13966. (Pubitemid 19214215)
27. Kumar JK, Tabor S, Richardson CC: Proteomic analysis of thioredoxin-targeted proteins in Escherichia coli Proc Natl Acad Sci USA 2004; 101: 3759-3764. (Pubitemid 38381051)
28. Masaki M, et al: Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB synergistically. Eur J Biochem 2003; 270: 76-83. (Pubitemid 36056939)
29. Knox RJ, et al: Mechanism of cytotoxicity of anticancer platinum drugs: Evidence that cis -diamminedichloroplatinum(II) and cis - diammine-(1,1- cyclobutanedicarboxylato) platinum(II) differ only in the kinetics of their interaction with DNA. Cancer Res 1986; 46: 1972-1979. (Pubitemid 16080411)